# Computational modeling of resistance to hormone-mediated remission in childhood absence epilepsy

**Authors:** Maliha Ahmed, Sue Ann Campbell

PMC · DOI: 10.3389/fncom.2025.1733650 · Frontiers in Computational Neuroscience · 2026-01-12

## TL;DR

This study uses a computational model to explore why some children with absence epilepsy do not respond to hormone-related treatments during puberty.

## Contribution

A novel thalamocortical model is introduced to explain how neuronal composition and connectivity affect treatment response in childhood absence epilepsy.

## Key findings

- Parietal-dominant networks with more RS neurons showed recovery from seizures after ALLO treatment.
- Frontocortical connectivity influenced the effectiveness of ALLO in resolving pathological brain activity.
- Neuronal composition modulates treatment outcomes, suggesting personalized strategies for CAE.

## Abstract

Childhood absence epilepsy (CAE) often resolves during adolescence, a period marked by hormonal and neurosteroid changes associated with puberty. However, remission does not occur in all individuals. To investigate this clinical heterogeneity, we developed a simplified thalamocortical model with a layered cortical structure, using deep-layer intrinsically bursting (IB) neurons to represent frontal cortex and regular spiking (RS) neurons modeling the parietal cortex. By simulating two cortical configurations, we explored how variations in neuronal composition and frontocortical connectivity influence seizure dynamics and the effectiveness of allopregnanolone (ALLO) in resolving pathological spike-wave discharges (SWDs) associated with CAE. While both models exhibited similar physiological and pathological oscillations, only the parietal-dominant network (with a higher proportion of RS neurons in layer 5) recovered from SWDs under increased frontocortical connectivity following ALLO administration. These findings suggest that neuronal composition critically modulates ALLO-mediated resolution of SWDs, providing a mechanistic link between structural connectivity and clinical outcomes in CAE, and highlighting the potential for personalized treatment strategies based on underlying network architecture.

## Linked entities

- **Chemicals:** allopregnanolone (PubChem CID 92786)
- **Diseases:** childhood absence epilepsy (MONDO:0010826)

## Full-text entities

- **Diseases:** seizure (MESH:D012640), CAE (MESH:D004832)
- **Chemicals:** ALLO (MESH:D011280)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12833357/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12833357/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12833357/full.md

---
Source: https://tomesphere.com/paper/PMC12833357